BioSig Technologies sees its PURE EP System highlighted in new feature article in EP Lab Digest

BioSig Technologies sees its PURE EP System highlighted in new feature article in EP Lab Digest

BioSig Technologies Inc (NASDAQ:BSGM) has seen its PURE EP System featured in the new edition of leading electrophysiology trade publication, EP Lab Digest. This is the second time that the computerized electrophysiology system has been highlighted in EP Lab Digest in 2021, having been mentioned in a January editorial by EP Lab’s editor-in-chief Bradley Knight.   Westport, Conneticut-based BioSig said that healthcare professionals at Memorial Hospital in South Bend, Indiana — Dr Deepak Gaba and Shari Slyder, managing director of cardiovascular services – talked about how they used PURE EP as part of their treatment regime in intracardiac signals in complex ablations. READ: BioSig Technologies says top-rated leading hospital system has purchased its PURE EP systems for multiple campuses in its national network Dr Gaba has performed more than twenty-five procedures using PURE EP to date, according to BioSig. “As we continue expanding our clinical footprint, we are rapidly learning how the cardiac information provided by PURE EP complements other technologies and elevates the experience in the electrophysiology lab,”  Olivier Chaudoir, BioSig’s senior director of marketing said in a statement. “The growing physician acceptance of our technology is a result of our dedication to addressing unmet clinical needs. We are pleased to see the increased industry’s focus on the importance of high-fidelity intracardiac signals across all types of cardiac arrhythmias.” The PURE EP System is being used various types of arrhythmia cases, including atrial fibrillation, ventricular tachycardia, and atrial flutter. More than 680 patient cases have been conducted with the technology to date. The full EP Lab Digest article can be read here: https://www.eplabdigest.com/improved-intracardiac-signal-visualization-during-rf-and-cryo-procedures Contact Angela at angela@proactiveinvestors.com Follow her on Twitter @AHarmantas

Post a Comment